A Th1-inducing adjuvant, MPL®, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines
Alan W. Wheeler, Jean S. Marshall, J. Terry Ulrich
科研成果: 期刊稿件 › 文章 › 同行评审
116
引用
（Scopus）